GENOME SYNTHESIS & DESIGN FUTURES:

A Multi-Client Scenarios Research Project

Bio-era is pleased to announce an expert, multi-client scenarios project to explore how rapid advances in gene sequencing and synthesis technologies will affect primary sectors of the U.S. economy in the years ahead.  Sponsored by the US Department of Energy and bio-era, the study will:

• Assess possible trajectories for the emergence, application, and diffusion of whole genome synthesis, genomic design, and related technologies, and the implications for selected sectors -- particularly energy, chemicals, and pharmaceutical production -- of the U.S. economy over the coming twenty-year period.
  
• Articulate highly plausible alternative futures and their implications for selected industries and economic sectors utilizing common assumptions regarding technology development, government and regulatory policies, public acceptance, and industry practice.

To request a full Prospectus and enrollment info, please click here and submit the completed form.  We will send you the information via e-mail.

Key questions to be answered:

• How fast will gene sequencing and synthesis technologies progress?
• What will be the future cost of gene sequencing and genome synthesis?
• What will be the most attractive and profitable applications?
• How could a successful open-source synthetic biology movement affect the future of the biotechnology industry?
• What does it mean to be able to "design" genomes from scratch? 
• How will primary sectors of the economy -- energy, agriculture, chemicals, and pharmaceuticals -- be affected by the emergence of a genomic design discipline?
• What are the biosecurity risks and how can they best be managed?

Who will benefit from this research?

• Marketing and business development executives from gene sequencing and synthesis technology companies -- this project will identify future markets for these technologies
• Biotechnology and pharmaceutical companies that use gene sequencing and synthesis technologies -- this project will identify cutting edge and competing technologies and technology providers, and will document how these technologies are likely to perform 
• Planning executives from energy, chemical, and agribusiness interested in tracking how emerging technologies with disruptive and strategic importance will affect their industries in the years ahead
• Academic researchers and others active in the fields of gene sequencing, synthesis and synthetic biology
• Government regulators and researchers from USDA, USDOE, FDA, EPA, Homeland Security and other federal agencies concerned with these emerging technologies 

Contents:

Co-sponsorship opportunities are also available!

Co-sponsor the study and take advantage of the opportunity to gain exposure for your company or organization while showing your support for the rapidly growing enabling biotech and synthetic biology industries!  As a sponsor, your identity and brand as a forward thinking industry booster and trailblazer will be heightened and reinforced.  Sponsorship offers the perfect opportunity to introduce your company or reinforce your message to the bio-era network.

Co-sponsorship benefits include:

• Your company name and logo prominently displayed as a co-sponsor:
  • On research products
  • On promotional materials
  • At events presenting
  • On websites
    
• Verbal recognition at bio-era events
  
• Keynote speaking opportunities at research conferences
  
• Special introductions to conference and study participants

Please click here and submit the form if you are interested in sponsoring this research program or service opportunity.  Alternatively, please call Steve Aldrich at 617 876-2400.

Sponsorship Cancellation Policy:

A cancellation fee of $500 US will be applied to all sponsorship cancellations received 91 days or more prior to the event.  No refunds will be issued 90 days or less prior to the event.  All cancellations must be in writing.

Excerpt from the Executive Summary

"Whether from the ground up or using snap together parts, whether proprietary or open source, genome synthesis will completely alter the economics of innovative biological design. Labor costs are decreasing rapidly while productivity is rising. New technologies will enable broad-based genetic design, and eventually, the fabrication of materials and structures locally at low cost. This is the beginning of “distributed biological manufacturing" – a new paradigm of materials production which should eventually be both less expensive and more efficient than traditional manufacturing processes in many industries."

Click here to enroll or get more info.

top